Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 35, 1995 - Issue 1
53
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Enhanced Levels of Colony Stimulating Factor-1 (Csf-1) in Sera and Seminal Plasma of Antisperm Antibody-Positive Infertile Men

&
Pages 5-11 | Published online: 09 Jul 2009
 

Abstract

This investigation was carried out to examine the levels of CSF-1 in sera and seminal plasma of fertile, immunoinfertile, and male factor-infertile men in order to study the role of CSF-1 in human infertility. Sera, sperm, and seminal plasma were analyzed for antisperm antibodies by the sperm immobilization technique, tray agglutination technique, and immunobead binding technique. Sperm motility and fertilizing capacity were analyzed by sperm motion analysis and sperm penetration assay, respectively. CSF-1 concentration was estimated by the competitive radioimmunoassay. CSF-1 was detected in sera of both fertile and immunoinfertile men (mean ± SD; fertile men: 52.9 ± 10.3 pg/mg protein; immunoinfertile: 58.2 ± 19.5 pg/mg proteinic p ±.05). CSF-1 was also detected in the seminal plasma of fertile, immunoinfertile, and male factor-infertile men (mean ± SD; normal fertile men: 1.7 ± 3.5 ng/mg; immunoinfertile men: 10.9 ± 15.6 ng/mg; male factor-infertile men: 0.85 ± 0.25 ng/mg). The levels of CSF-1 were highest in the immunoinfertile men, followed by those in fertile and male factor-infertile men. The average level in immunoinfertile men was significantly different from the average level in fertile or male factor-infertile men (p <. 0001). Interestingly, the concentrations of CSF-1 per milliliter of seminal plasma was in general approximately 5 times greater than those in serum. These findings indicate that elevated seminal plasma CSF-1 concentration is correlated with male infertility.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.